The Role of probiotics in antibiotic-associated diarrhea, acute diarrhea and functional constipation in children
DOI:
https://doi.org/10.12775/JEHS.2024.76.56616Keywords
Probiotics, Gut microbiota, Acute gastroenteritis, Antibiotic-associated diarrhea in children, Functional constipation, Probiotics in pediatricsAbstract
Introduction and purpose
Probiotics are widely used by parents of children, as well as by heathcare professionals. Because of their long history of presence on the market they have become an evident addition to the treatment of gastrointestinal disorders. The aim of this review is to emphasize what are the current recommendations for the use of probiotics in children in antibiotic-associated diarrhea (AAD), acute diarrhea and functional constipation, determine what the safety of their use is, and what to look for when choosing a product.
Material and methods
For this review, we used the literature available in PubMed and Google Scholar using the following keywords: “probiotics”, “probiotics in pediatrics”, “gut microbiota”, “acute gastroenteritis”, “AAD in children”, “functional constipation”.
Brief description of the state of knowledge
Probiotics are often used in pediatrics despite their uncertain efficiency. At the same time, there is a focus on the quality, purity and appropriate dosage of preparations available on the market. Extra precaution must be taken when administering a preparation or refraining from administering a probiotic to children with immune disorders. The benefit of their use mostly in AAD in children is difficult to determine.
Conclusion
Probiotics may be considered during antibiotic therapy in children if a broad-spectrum antibiotic is being used, the duration of therapy is prolonged, or there are other risk factors for AAD in children. In acute gastroenteritis, probiotics can be considered; however, their effectiveness is limited. Probiotics should not be used in the treatment of functional constipation. It is preferable to use probiotics in the form of a medicine. The efficacy of probiotics is both strain-specific and disease-specific.
References
Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell 2016;164(3):337-40 doi: 10.1016/j.cell.2016.01.013.
Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision Nutrition and the Microbiome, Part I:Current State of the Science. Nutrients 2019;11(4):923 doi: 10.3390/nu11040923.
Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, Vinderola G. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 2021;18(9):649-667. doi: 10.1038/s41575-021-00440-6. Epub 2021 May 4.
Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, Çokuğraş FC, Pettoello-Mantovani M, Kolaček S. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups.Acta Paediatr. 2018;107(6):927-937. doi: 10.1111/apa.14270.
Szajewska H, Kołodziej M, Gieruszczak-Białek D, Skórka A, Ruszczyński M, Shamir R. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update. Aliment Pharmacol Ther. 2019;49(11):1376-1384. doi: 10.1111/apt.15267.
Puebla-Barragan S, Reid G. Probiotics in Cosmetic and Personal Care Products: Trends and Challenges. Molecules 2021;26(5):1249. doi: 10.3390/molecules26051249.
FAO/WHO Expert Consultation: Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. doi: 10.1038/nrgastro.2014.66.
Depoorter L, Vandenplas Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients2021;13(7):2176. doi: 10.3390/nu13072176.
Liao W, Chen C, Wen T, Zhao Q. Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials. J Clin Gastroenterol 2021;55(6):469-480. doi: 10.1097/MCG.0000000000001464.
Bäumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 2016;535(7610):85-93. doi: 10.1038/nature18849.
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open 2021;11:e043054. doi: 10.1136/bmjopen-2020-043054.
Łukasik J, Guo Q, Boulos L, Szajewska H, Johnston BC. Probiotics for the prevention of antibiotic-associated adverse events in children-A scoping review to inform development of a core outcome set. PLoS One 2020;15(5):e0228824. doi: 10.1371/journal.pone.0228824.
Łukasik J, Dierikx T, Besseling-van der Vaart I, de Meij T, Szajewska H. Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children. JAMA Pediatr. 2022;176(9):860–866. doi: 10.1001/jamapediatrics.2022.1973.
Szajewska H, Canani RB, Guarino A, et al; ESPGHAN Working Group for Probiotics. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 2016;62(3):495-506. doi:10.1097/MPG.0000000000001081.
Baù M, Moretti A, Bertoni E, Vazzoler V, Luini C, Agosti M, Salvatore S. Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study. Pediatr Gastroenterol Hepatol Nutr 2020;23(1):35-48. doi: 10.5223/pghn.2020.23.1.35.
Suniega EA, Frasca J. Probiotics to Prevent Antibiotic-Associated Diarrhea in Children. Am Fam Physician. 2020;101(5):Online
Szajewska H, Canani RB, Domellöf M et al. Probiotics for the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. J Pediatr Gastroenterol Nutr 2023;76(2):232-247.doi: 10.1097/MPG.0000000000003633.
Goldenberg JZ, Yap C, Lytvyn L, Lo CKF, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;10;2010(11):CD003048. doi: 10.1002/14651858.
Guarino A., Ashkenazi S., Gendrel D. et al.: European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr., 2014; 59: 132–152. doi: 10.1097/MPG.0000000000000375.
Urbańska M, Gieruszczak-Białek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther. 2016;43(10):1025-34. doi: 10.1111/apt.13590. doi: 10.1111/apt.13590.
Rodríguez-Díaz J, Monedero V. Probiotics against Digestive Tract Viral Infections. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2012:271–284. doi: 10.1016/B978-0-12-397154-8.00031-2.
Su GL, Ko CW, Bercik P, Falck-Ytter Y,Sultan S, Weizman AV, Morgan RL. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology 2020;159(2):697-705. doi: 10.1053/j.gastro.2020.05.059.
Chen K, Jin S, Ma Y , Cai L, Xu P, Nie Y, Luo L, Yu G, Shen Y, Ma W, Zhou Z, Liu C. Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study. Nutrition 2023:111:112052.doi:10.1016/j.nut.2023.112052. doi: 10.1016/j.nut.2023.112052.
Ianiro G, Rizzatti G, Plomer M, Lopetuso L, Scaldaferri F, Francesch F, Cammarota G, Gasbarrini A. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2018;10(8):1074. doi: 10.3390/nu10081074.
Altcheh J, Carosella MV, Ceballos A et al. Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis. Medicine (Baltimore) 2022;101(36):e30500. doi: 10.1097/MD.0000000000030500.
Hojsak I, Szajewska H, Canani RB, et al. Probiotics for the Prevention of Nosocomial Diarrhea in Children. J Pediatr Gastroenterol Nutr. 2018;66(1):3-9. doi: 10.1097/MPG.0000000000001637.
Bruzzese E, Fedele MC, Bruzzese D, Viscovo S, Giannattasio A, Mandato C, Siani P, Guarino A. Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo. Aliment Pharmacol Ther. 2016;44(6):568-75. doi: 10.1111/apt.13740.
Wegh CA, Baaleman DF, Tabbers MM, Smidt H, Benninga MA. Nonpharmacologic Treatment for Children with Functional Constipation: A Systematic Review and Meta-analysis. J Pediatr 2022:240:136-149. doi: 10.1016/j.jpeds.2021.09.010.
Benninga MA, Faure C, Hyman PE, Roberts I, Schechter NL, Nurko S. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology. 2016 Feb 15:S0016-5085(16)00182-7. doi: 10.1053/j.gastro.2016.02.016.
Levy EI, Lemmens R, Vandenplas Y, Devreker T. Functional constipation in children: challenges and solutions. Pediatric Health Med Ther. 2017:8:19-27. doi: 10.2147/PHMT.S110940.
Dimidi E, Christodoulides S, Scott M, Whelan K. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr 2017;8(3):484-494.
Huang R, Hu J. Positive Effect of Probiotics on Constipation in Children: A Systematic Review and Meta-Analysis of Six Randomized Controlled Trials. Front Cell Infect Microbiol. 2017:7:153. doi: 10.3389/fcimb.2017.00153.
McFarland LV, Hecht G, Sanders ME et al. Recommendations to Improve Quality of Probiotic Systematic Reviews With Meta-Analyses. JAMA Netw Open 2023;6(12):e2346872. doi: 10.1001/jamanetworkopen.2023.46872. doi: 10.1001/jamanetworkopen.2023.46872.
Rau S, Gregg A, Yaceczko S, Limketkai B. Prebiotics and Probiotics for Gastrointestinal Disorders. Nutrients. 2024;16(6):778. doi: 10.3390/nu16060778.
de Simone C. The Unregulated Probiotic Market. Clin Gastroenterol Hepatol 2019;17(5):809-817. doi: 10.1016/j.cgh.2018.01.018.
D'Agostin M, Squillaci D, Lazzerini M, Barbi E, Wijers L, Da Lozzo P. Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review. Children (Basel) 2021;8(10):924. doi: 10.3390/children8100924.
Szajewska H. What are the indications for using probiotics in children? Arch Dis Child 2016;101(4):398-403. doi: 10.1136/archdischild-2015-308656.
Sotoudegan F, Daniali M., Hassani S, Nikfar S, Abdollahi M. Reappraisal of probiotics’ safety in human. Food Chem. Toxicol.2019, 129, 22. doi: 10.1016/j.fct.2019.04.032.
Guamán LP, CaGrrera-Pacheco SE, Zúñiga-Miranda J, Teran E, Erazo C, Barba-Ostria C. The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review. Nutrients 2024;16(21):3706. doi: 10.3390/nu16213706.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Urszula Korotko, Mikołaj Biskupski, Aleksandra Cygnarowicz, Negar Hosseinnejad, Aneta Mandziuk, Karolina Sacher, Mariola Turemka, Kinga Witowska, Aneta Klaudia Wojtas, Krystyna Zabojska, Jakub Chodkowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 307
Number of citations: 0
